Tiruppathi C, Finnegan A, Malik A B
Department of Pharmacology, Rush-Presbyterian-St. Luke's Medical Center/Rush Medical College, Chicago, IL 60612-3824, USA.
Proc Natl Acad Sci U S A. 1996 Jan 9;93(1):250-4. doi: 10.1073/pnas.93.1.250.
Albumin-binding proteins identified in vascular endothelial cells have been postulated to contribute to the transport of albumin via a process involving transcytosis. In the present study, we have purified and characterized a 57- to 60-kDa (gp60) putative albumin-binding protein from bovine pulmonary microvessel endothelial cells. The endothelial cell membranes were isolated from cultured cells by differential centrifugation and solubilized with sodium cholate and urea. The solubilized extract was concentrated after dialysis by ethanol precipitation and reextracted with Triton X-100, and the resulting extract was subjected to DEAE-cellulose column chromatography. Proteins eluted from this column were further separated using preparative sodium dodecyl sulfate/polyacrylamide gel electrophoresis and used for immunizing rabbits. Fluorescence-activated cell sorter analysis using the anti-gp60 antibodies demonstrated the expression of gp60 on the endothelial cell surface. Affinity-purified anti-gp60 antibodies inhibited approximately 90% of the specific binding of 125I-labeled albumin to bovine pulmonary microvessel endothelial cell surface. The anti-gp60 antibodies reacted with gp60 from bovine pulmonary artery, bovine pulmonary microvessel, human umbilical vein, and rat lung endothelial cell membranes. Bovine anti-gp60 antibodies also reacted with bovine secreted protein, acidic and rich in cysteine (SPARC). However, bovine SPARC NH2-terminal sequence (1-56 residues) antibodies did not react with gp60, indicating that the endothelial cell-surface-associated albumin-binding protein gp60 was different from the secreted albumin-binding protein SPARC. We conclude that the endothelial cell-surface-associated gp60 mediates the specific binding of native albumin to endothelial cells and thus may regulate the uptake of albumin and its transcytosis.
血管内皮细胞中鉴定出的白蛋白结合蛋白被推测通过涉及转胞吞作用的过程促进白蛋白的运输。在本研究中,我们从牛肺微血管内皮细胞中纯化并鉴定了一种57至60 kDa(gp60)的假定白蛋白结合蛋白。通过差速离心从培养细胞中分离出内皮细胞膜,并用胆酸钠和尿素溶解。溶解后的提取物经乙醇沉淀透析浓缩,再用Triton X-100重新提取,所得提取物进行DEAE-纤维素柱层析。从该柱上洗脱的蛋白质进一步通过制备性十二烷基硫酸钠/聚丙烯酰胺凝胶电泳分离,并用于免疫兔子。使用抗gp60抗体的荧光激活细胞分选分析表明gp60在内皮细胞表面表达。亲和纯化的抗gp60抗体抑制了约90%的125I标记白蛋白与牛肺微血管内皮细胞表面的特异性结合。抗gp60抗体与来自牛肺动脉、牛肺微血管、人脐静脉和大鼠肺内皮细胞膜的gp60发生反应。牛抗gp60抗体也与牛分泌的富含半胱氨酸的酸性蛋白(SPARC)发生反应。然而,牛SPARC NH2末端序列(1-56个残基)抗体不与gp60反应,表明内皮细胞表面相关的白蛋白结合蛋白gp60与分泌的白蛋白结合蛋白SPARC不同。我们得出结论,内皮细胞表面相关的gp60介导天然白蛋白与内皮细胞的特异性结合,因此可能调节白蛋白的摄取及其转胞吞作用。